Literature DB >> 16611672

Anthracycline cardiotoxicity.

Paul G Horan, Mary Frances McMullin, Pascal P McKeown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16611672     DOI： 10.1093/eurheartj/ehi702

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats.

Authors:  Livan Delgado-Roche; Yanet Hernández-Matos; Emilio A Medina; Dalia Á Morejón; Maité R González; Gregorio Martínez-Sánchez
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

2.  Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury.

Authors:  Chotiros Daosukho; Yumin Chen; Teresa Noel; Pradoldej Sompol; Ramaneeya Nithipongvanitch; Joyce M Velez; Terry D Oberley; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

3.  Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.

Authors:  Izabela Piotrowska; Mark Isalan; Michal Mielcarek
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 4.  Anthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis.

Authors:  Wu Ding; Zhian Li; Caiyun Wang; Jiangfeng Dai; GuoDong Ruan; Chuanjian Tu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.